The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Association Between High Homocyst(e)ine and Ischemic Stroke due to Large- and Small-Artery Disease but Not Other Etiologic Subtypes of Ischemic Stroke
Abstract
Background and Purpose —Elevated plasma homocyst(e)ine may be a causal and modifiable risk factor for ischemic stroke, but the results of previous studies have been conflicting. One possible explanation is that homocyst(e)ine may only be associated with certain pathophysiological subtypes of ischemic stroke. Methods —We conducted a case-control study of 219 hospital cases with a first-ever ischemic stroke and 205 randomly selected community control subjects stratified by age, sex, and postal code. With the use of established criteria, cases of stroke were classified by etiologic subtype in a blinded fashion. The prevalence of conventional vascular risk factors, fasting plasma homocyst(e)ine levels, vitamin levels, and nucleotide 677 methylene tetrahydrofolate reductase (MTHFR) genotypes were determined in cases and controls. Results —Increasing homocyst(e)ine was a strong and independent risk factor for ischemic stroke (adjusted OR 2.7, 95% CI 1.4 to 5.1 for a 5-μmol/L increase in fasting plasma homocyst(e)ine from 10 to 15 μmol/L). Compared with the lowest quartile, the highest quartile of homocyst(e)ine was associated with an adjusted OR of ischemic stroke of 2.2 (95% CI 1.1 to 4.2). Mean plasma homocyst(e)ine was significantly higher in cases of ischemic stroke due to large-artery disease (14.1 μmol/L, 95% CI 12.5 to 15.9, P <0.001) and small-artery disease (12.7 μmol/L, 95% CI 11.4 to 14.1, P =0.004) compared with control subjects (10.5 μmol/L; 95% CI 10.0 to 11.0) but not in cardioembolic or other etiologic subtypes of ischemic stroke. Compared with the lowest quartile of homocyst(e)ine, the upper 3 quartiles were associated with an adjusted OR of ischemic stroke due to large-artery disease of 3.0 (95% CI 0.8 to 10.8) for the second quartile, 5.6 (95% CI 1.6 to 20) for the third quartile, and 8.7 (95% CI 2.4 to 32) for the fourth quartile ( P for trend=0.0005). However, despite a clear association between the TT MTHFR genotype and elevated fasting plasma homocyst(e)ine, there was no association between MTHFR genotype and ischemic stroke or subtype of ischemic stroke. Conclusions —There is a strong, graded association between increasing plasma homocyst(e)ine and ischemic stroke caused by large-artery atherosclerosis and, to a much lesser extent, small-artery disease, but not cardioembolic or other etiologic subtypes of ischemic stroke. Our results are consistent with the hypothesis that the deleterious effect of high homocyst(e)ine is mediated primarily via a proatherogenic effect.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study
Murray, C. J., & Lopez, A. D. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07495-8 · Cited by 4,492 · cited 1×
“) (who remained blinded to the results of homocyst(e)ine and vitamin assays and MTHFR genotype) classified all strokes into 4 major etiologic subtypes according to the following predefined criteria11: (1) large-artery disease: ischemic stroke with (a) evidence of extracranial or intracranial occlusive large-artery dis…”
Mortality by cause for eight regions of the world: Global Burden of Disease Study
Murray, C. J., & Lopez, A. D. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07493-4 · Cited by 4,043
Cited by
Casas, J. P., Hingorani, A. D., Bautista, L. E., & Sharma, P. (2004) · Archives of Neurology · doi:10.1001/archneur.61.11.1652 · Cited by 386
Homocysteine is a risk factor for cerebral small vessel disease, acting via endothelial dysfunction
Hassan, A. (2004) · Brain · doi:10.1093/brain/awh023 · Cited by 338
The Homocysteine Hypothesis of Depression
Folstein, M., Liu, T., Peter, I., Buel, J., Arsenault, L., Scott, T., & Qiu, W. W. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.6.861 · Cited by 262
Endothelial dysfunction in lacunar stroke: a systematic review
Knottnerus, I. L. H., Ten Cate, H., Lodder, J., Kessels, F., & van Oostenbrugge, R. J. (2009) · Cerebrovascular Diseases · doi:10.1159/000212672 · Cited by 137
Homocysteine and cognitive function in healthy elderly community dwellers in Italy
Ravaglia, G., Forti, P., Maioli, F., Muscari, A., Sacchetti, L., Arnone, G., Nativio, V., Talerico, T., & Mariani, E. (2003) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/77.3.668 · Cited by 131
Notsu, Y., Nabika, T., Bokura, H., Suyama, Y., Kobayashi, S., Yamaguchi, S., & Masuda, J. (2009) · American Journal of Hypertension · doi:10.1038/ajh.2008.346 · Cited by 36
Miyaki, K., Song, Y., Htun, N. C., Tsutsumi, A., Hashimoto, H., Kawakami, N., Takahashi, M., Shimazu, A., Inoue, A., Kurioka, S., et al. (2012) · BMC Psychiatry · doi:10.1186/1471-244x-12-33 · Cited by 35
Sato, Y., Honda, Y., Iwamoto, J., Kanoko, T., & Satoh, K. (2005) · JAMA · doi:10.1001/jama.293.9.1082 · Cited by 2
Retracted
Metadata
- Authors
- Eikelboom, J. W., Hankey, G. J., Anand, S. S., Lofthouse, E., Staples, N., & Baker, R. I.
- Venue
- Stroke
- Published
- 2000-05
- Volume
- 31
- Issue
- 5
- Pages
- 1069-1075
- ISSN
- 0039-2499 (ISSN-L)
- 1524-4628
- OpenAlex
- W2114433642
- Cited by
- 248
- References
- 2
- FWCI
- 10.81
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.